Veru
VERU
#10341
Rank
NZ$80.19 M
Marketcap
NZ$4.70
Share price
2.23%
Change (1 day)
-15.95%
Change (1 year)

Earnings for Veru (VERU)

Earnings in 2026 (TTM): -NZ$47.96 Million

According to Veru's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$51.33 Million, an increase over its 2024 earnings that were of -NZ$65.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Veru from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$47.96 Million-6.56%
2025 -NZ$51.33 Million-21.84%
2024 -NZ$65.67 Million-49.67%
2023 -NZ$0.14 Billion-31.87%
2022 -NZ$0.2 Billion673.72%
2021 -NZ$24.76 Million-375.47%
2020 NZ$8.98 M-157.74%
2019 -NZ$15.57 Million-32.09%
2018 -NZ$22.92 Million1.17%
2017 -NZ$22.65 Million-1349.01%
2016 NZ$1.81 M-85.97%
2015 NZ$12.92 M99.18%
2014 NZ$6.48 M-51.18%
2013 NZ$13.29 M-33.9%
2012 NZ$20.1 M108.3%
2011 NZ$9.65 M3.75%
2010 NZ$9.3 M-20.61%
2009 NZ$11.72 M136.88%
2008 NZ$4.94 M
2006 -NZ$0.14 Million26.36%
2005 -NZ$0.11 Million
2000 -NZ$3.75 Million
1998 -NZ$5.05 Million-37.72%
1997 -NZ$8.11 Million-47.64%
1996 -NZ$15.48 Million37.12%
1995 -NZ$11.29 Million-15.38%
1994 -NZ$13.35 Million875%
1993 -NZ$1.37 Million-50%
1992 -NZ$2.74 Million-0%
1991 -NZ$2.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.4 Billion 713.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$31.06 Million-35.46%๐Ÿ‡บ๐Ÿ‡ธ USA